cyclohexanol has been researched along with Bipolar Disorder in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (14.71) | 18.2507 |
2000's | 41 (60.29) | 29.6817 |
2010's | 17 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aarya, KR; Grover, S; Sharma, A | 1 |
Ferentinos, P; Gournellis, R; Michopoulos, I; Oulis, P | 1 |
Stevens, AW; Tak, LM | 1 |
Miller, MC | 1 |
Guerra, MW; Shults, J | 1 |
Deckert, J; Hempel, S; Kopf, J; Olmes, D; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Schmidt, B; Unterecker, S | 1 |
Pearlstein, T | 1 |
Amsterdam, JD; Shults, J | 2 |
Kaplan, P; Kora, K | 1 |
Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T | 1 |
Hardy-Baylé, MC; Passerieux, C | 1 |
Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
Amsterdam, JD; Shults, J; Wang, G | 1 |
Baune, BT; Caliskan, S; Todder, D | 2 |
Grønli, O; Olstad, R; Stensland, GØ; Wynn, R | 1 |
Kahn, DA; Kalia, R; Khan, AY; Magsalin, RM | 1 |
Guico-Pabia, CJ; Jiang, Q; Lobello, KW; Nichols, AI; Ninan, PT; Patroneva, A; Paul, J; Preskorn, SH | 1 |
Chang, CH; Chen, SJ; Tsai, HC | 1 |
Bujoreanu, IS; DeMaso, DR; Ibeziako, P | 1 |
Agius, M; Davis, A; Gilhooley, M; Zaman, R | 1 |
Agius, M; Bugler, R; Tavormina, G; Zaman, R | 1 |
Del Casale, A; Girardi, P; Innamorati, M; Lester, D; Mancini, M; Pompili, M; Serafini, G; Tatarelli, R | 1 |
Bradshaw, DA; Crosby, MI; McLay, RN | 1 |
Praharaj, SK | 1 |
Frölich, L; Hausner, L; Janke, C; Kranaster, L; Sartorius, A | 1 |
Adamou, M; Hale, AS | 1 |
Fava, GA; Mangelli, L | 1 |
Arguisola, MS; Tavakoli, SA | 1 |
Amsterdam, JD; Brunswick, DJ | 1 |
Chand, PK; Kalyani, GS; Murthy, P | 1 |
Becker, OV; Glenn, T; Ketter, TA; Marsh, WK; Rasgon, NL | 1 |
Basterzi, AD; Goka, E; Yuksel, FV | 1 |
Hauser, P; Hisley, KC; Lefkowitz, DM; Marano, C; Obuchowski, A; Regenold, WT | 1 |
Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U | 1 |
Florkowski, A; Gałecki, P; Gruszczyński, W; Kołodziejska, I; Mikołajczyk, I; Zboralski, K | 1 |
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
Liau, CH; Shen, WW; Su, KP | 1 |
Kennedy, SH | 1 |
Aydin, C; Bildik, T; Erermis, S; Gokcen, S; Korkmaz, S; Ozbaran, B; Tamar, M | 1 |
Egger, C; Geretsegger, C; Muehlbacher, M; Nickel, M; Stuppaeck, C | 1 |
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
Mattes, JA | 1 |
Krol, DG; Nolen, WA | 1 |
Khazaal, Y | 1 |
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
Klier, CM; Mossaheb, N; Saria, A; Schloegelhofer, M; Zernig, G | 1 |
Amsterdam, JD; Shults, J; Shwarz, M; Wang, CH | 1 |
Hyllested, M; Klysner, R; Larsen, JK; Pedersen, BD; Sørensen, P | 1 |
Gitlin, MJ | 1 |
Jenkins, P; Wilson, R | 1 |
Mekler, G; Woggon, B | 1 |
Blennerhassett, J; Parker, G | 1 |
Spier, SA | 1 |
Amsterdam, J | 1 |
Ramlatchman, L; Stoner, SC; Williams, RJ; Worrel, J | 1 |
Borgherini, G; Conforti, D; Fiorellini Bernardis, LA; Magni, G | 1 |
Brown, ES; Hong, SC | 1 |
Amsterdam, JD; Garcia-España, F | 1 |
Golden, RN; Nicholas, L | 1 |
Caputo, RM; Stern, S; Votolato, NA | 1 |
Nayudu, S; Scheftner, WA; Shulman, RB | 1 |
Linden, M; Ludewig, K; Munz, T | 1 |
Gupta, N | 1 |
Grube, M; Pfeffer, F | 1 |
Benabarre, A; Colom, F; Goikolea, JM; Martinez-Arán, A; Reinares, M; Torrent, C; Vieta, E | 1 |
6 review(s) available for cyclohexanol and Bipolar Disorder
Article | Year |
---|---|
Perinatal depression: treatment options and dilemmas.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cyclohexanols; Depression, Postpartum; Depressive Disorder; Female; Fetal Diseases; Humans; Infant, Newborn; Lithium Carbonate; Perinatology; Pregnancy; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride | 2008 |
[Mood disorders].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
Psychiatric concerns in pediatric epilepsy.
Topics: Adolescent; Amines; Anxiety Disorders; Bipolar Disorder; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Cyclohexanols; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Mental Disorders; Norepinephrine; Pregabalin; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride; Young Adult | 2010 |
Antidepressant monotherapy for bipolar type II major depression.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Lamotrigine add-on therapy to venlafaxine treatment in adolescent-onset bipolar II disorder: a case report covering an 8-month observation period.
Topics: Adolescent; Age of Onset; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Humans; Lamotrigine; Male; Psychiatric Status Rating Scales; Treatment Outcome; Triazines; Venlafaxine Hydrochloride | 2006 |
Antidepressant efficacy of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
14 trial(s) available for cyclohexanol and Bipolar Disorder
Article | Year |
---|---|
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride; Young Adult | 2014 |
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Personality Inventory; Psychometrics; Retreatment; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenotype; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Retrospective Studies; Thiophenes; Venlafaxine Hydrochloride | 2010 |
[Trazodone and venlafaxine in treatment of depressive disorders].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Arousal; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Quetiapine Fumarate; Sleep; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Capsules; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lithium Carbonate; Lithium Compounds; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Lithium Compounds; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Retrospective Studies; Sex Factors; Venlafaxine Hydrochloride | 2000 |
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
48 other study(ies) available for cyclohexanol and Bipolar Disorder
Article | Year |
---|---|
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride | 2013 |
Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Quetiapine Fumarate; Restless Legs Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
[Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
When depression doesn't lead with depression.
Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
A note on implementation of decaying product correlation structures for quasi-least squares.
Topics: Algorithms; Antidepressive Agents; Biostatistics; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanols; Humans; Least-Squares Analysis; Lithium Compounds; Longitudinal Studies; Models, Statistical; Venlafaxine Hydrochloride | 2014 |
[Hypomania/mania induced by cessation of antidepressant drugs].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2008 |
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.
Topics: Actigraphy; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Personality Inventory; Prognosis; Prospective Studies; Quetiapine Fumarate; Signal Processing, Computer-Assisted; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Neurotrophic factors in serum following ECT: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride | 2009 |
Mania possibly induced by desvenlafaxine.
Topics: Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Male; Middle Aged | 2010 |
Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.
Topics: Bipolar Disorder; China; Cyclohexanols; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Suicide risk and choice of antidepressant.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Female; Humans; Male; Practice Patterns, Physicians'; Risk Assessment; Secondary Prevention; Sex Factors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride | 2010 |
The bipolar spectrum: do we need a single algorithm for affective disorders?
Topics: Algorithms; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Humans; Practice Guidelines as Topic; Primary Health Care; Referral and Consultation; Risk Factors; Venlafaxine Hydrochloride | 2010 |
Severe mania complicating treatment of narcolepsy with cataplexy.
Topics: Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Modafinil; Narcolepsy; Venlafaxine Hydrochloride; Young Adult | 2011 |
Repetitive transcranial magnetic stimulation or venlafaxine-induced mania?
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2011 |
Venlafaxin-associated post-ictal asystole during electroconvulsive therapy.
Topics: Aged, 80 and over; Bipolar Disorder; Contraindications; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Heart Arrest; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Erotomania induced by venlafaxine: a case study.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Delusions; Depressive Disorder; Female; Humans; Love; Venlafaxine Hydrochloride | 2003 |
Mania associated with venlafaxine discontinuation.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depression; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2003 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
Venlafaxine-associated hypomania in unipolar depression.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Chronobiology Phenomena; Cyclohexanols; Drug Resistance; Female; Follicular Phase; Humans; Lamotrigine; Menstruation; Thyroxine; Triazines; Valproic Acid; Venlafaxine Hydrochloride | 2004 |
Venlafaxine-induced mania.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride | 2004 |
Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
Topics: Adult; Aged; Bipolar Disorder; Blood Glucose; Brain; Brain Diseases, Metabolic; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucans; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Psychotic Disorders; Psychotropic Drugs; Reference Values; Risk Factors; Sorbitol; Statistics as Topic; Venlafaxine Hydrochloride | 2005 |
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride | 2005 |
Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2006 |
Treatment guidelines for mania.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Female; Humans; Patient Compliance; Venlafaxine Hydrochloride | 2006 |
A case of recurrent hyponatremia induced by venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Female; Humans; Hyponatremia; Recurrence; Venlafaxine Hydrochloride | 2006 |
Less mood switching with venlafaxine?
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Humans; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Humans; Male; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy Trimesters; Quetiapine Fumarate; Sleep Wake Disorders; Trazodone; Venlafaxine Hydrochloride | 2007 |
Toxic interaction of venlafaxine and isocarboxazide.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Interactions; Humans; Isocarboxazid; Male; Monoamine Oxidase Inhibitors; Mydriasis; Selective Serotonin Reuptake Inhibitors; Shivering; Sweating; Venlafaxine Hydrochloride | 1995 |
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Suspected complication of treatment with venlafaxine.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Middle Aged; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
A case of serotonin syndrome caused by venlafaxine and lithium.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanols; Drug Interactions; Female; Humans; Lithium Compounds; Middle Aged; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride | 1997 |
Withdrawal reactions associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinations; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Use of bupropion with SRIs and venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Possible venlafaxine-induced mania.
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
Topics: Aged; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Bipolar Disorder; Cyclohexanols; Drug Combinations; Drug Interactions; Humans; Male; Nortriptyline; Valproic Acid; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced bruxism successfully treated with gabapentin.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bruxism; Cyclohexanecarboxylic Acids; Cyclohexanols; Depression; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1999 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-associated mania.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
[Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic].
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Utilization; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Neurology; Patient Admission; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Venlafaxine-induced hypomanic switch in bipolar depression.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride | 2001 |
Consensus guidelines outline drug selection and sequencing options for bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Practice Guidelines as Topic; Valproic Acid | 2000 |
An organic psychosis due to a venlafaxine-propafenone interaction.
Topics: Aged; Bipolar Disorder; Cyclohexanols; Drug Interactions; Female; Humans; Propafenone; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2001 |